Farrell High School students are raising awareness for an important cause--donating blood for sickle cell anemia.

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...

Khaberni - The 'Tawasol' electronic participation portal has published the pre-marital medical examination system for the ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

Ryan Murphy’s new FX series “The Beauty” starts with the bottom line that everyone wants to look great. The big question then ...

Columnist Michelle Harlan, who's currently taking hydroxyurea to treat her sickle beta-zero thalassemia, considers some other ...